Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management
- 28 April 2003
- journal article
- research article
- Published by Wiley in Clinical Transplantation
- Vol. 17 (2) , 77-88
- https://doi.org/10.1034/j.1399-0012.2003.00013.x
Abstract
Each year, 55 000 organ transplants are performed worldwide. Cumulatively, the number of living organ recipients is now estimated to be over 300 000. Most of these transplant recipients wi...Keywords
This publication has 17 references indexed in Scilit:
- Quantitation of Immunosuppression by Tacrolimus Using Flow Cytometric Analysis of Interleukin-2 and Interferon-γ Inhibition in CD8− and CD8+ Peripheral Blood T CellsTherapeutic Drug Monitoring, 2001
- Clinical Utility of Monitoring Tacrolimus Blood Concentrations in Liver Transplant PatientsThe Journal of Clinical Pharmacology, 2001
- Immunosuppressive medications for renal transplantation: A multiple choice questionKidney International, 2001
- Consensus Document: Therapeutic Monitoring of Tacrolimus (FK-506)Therapeutic Drug Monitoring, 1995
- A Two-Component Model for Measurement Error in Analytical ChemistryTechnometrics, 1995
- Racial Differences in the Survival of Cadaveric Renal AllograftsNew England Journal of Medicine, 1992
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991
- PROLIFERATIVE RESPONSES OF BRONCHOALVEOLAR LAVAGE LYMPHOCYTES FROM HEART-LUNG TRANSPLANT PATIENTSTransplantation, 1990
- Use of a Monoclonal Antibody for the Therapeutic Monitoring of Cyclosporine in Plasma and Whole BloodTherapeutic Drug Monitoring, 1988
- Anesthesia-associated depression in lymphocyte traffic and its modulationThe American Journal of Surgery, 1984